Ethereum price is trading near $1,928 after six consecutive red monthly closes, with mounting technical pressure below $1,940 raising the risk of a deeper slideEthereum price is trading near $1,928 after six consecutive red monthly closes, with mounting technical pressure below $1,940 raising the risk of a deeper slide

Ethereum (ETH) Price Prediction: Six Red Months Raise Pressure as $1,940 Breakdown Risks Slide Towards $1,700

2026/03/02 22:26
Okuma süresi: 3 dk
Bu içerikle ilgili geri bildirim veya endişeleriniz için lütfen [email protected] üzerinden bizimle iletişime geçin.

Ethereum price is entering a technically fragile phase after closing its sixth consecutive month in the red, with the price now hovering near $1,928. Persistent selling pressure, weakening momentum, and growing bearish positioning are raising the probability of a deeper corrective.

According to Brave New Coin data, Ethereum is trading near $1,928, down 3.76% in the last 24 hours. While short-term stabilization attempts are visible, the broader structure continues to lean bearish.

Six Consecutive Red Monthly Closes Signal Structural Weakness

Market analyst TedPillows recently highlighted that Ethereum has now closed six straight months in the red. More notably, ETH has closed 12 of the last 15 months negatively, a rare stretch of sustained underperformance for the asset.

Ethereum closes six consecutive red monthly candles, marking one of its longest sustained downturns in recent history. Source: TedPillows via X

Historically, extended red streaks can either precede:

  • A capitulation flush before reversal, or
  • Continued grind-down compression before another leg lower

While such streaks often lead to eventual relief rallies, they also reflect persistent distribution rather than accumulation. Until monthly momentum stabilizes, long-term structure remains under pressure.

Ethereum Price Prediction Targeting $1,700

Short-term technical analysis from Crypto Chiefs suggests Ethereum’s structure remains vulnerable below the $1,940 level. As long as ETH trades beneath this pivot, downside continuation towards $1,700 becomes increasingly probable.

The chart structure shows:

  • A breakdown from prior consolidation
  • Failure to sustain higher highs
  • Weak bounce attempts into resistance
  • If $1,940 is not reclaimed convincingly, sellers may continue targeting the $1,800 zone first, followed by a potential move into the $1,700 demand area.

Ethereum breaks down below $1,940, with weakening structure opening the door towards $1,800 and potentially the $1,700 demand zone. Source: Crypto Chiefs via X

Daily Range Compression Between $1.8K and $2.1K

Adding broader context, ChiefraFba pointed out that Ethereum price is currently trading within a daily range, with major support in the lower $1.8K area and resistance near $2.1K. This range compression suggests a larger move is building.

Ethereum consolidates between $1.8K support and $2.1K resistance. Source: ChiefraFba via X

However, after a strong downward impulse earlier in the month, range formations that occur below resistance typically resolve in the direction of the dominant trend, which currently favors sellers. A clean break below $1,800 would likely accelerate volatility. Conversely, only a reclaim above $2,100 would meaningfully shift structural bias.

Ethereum and Whale Activity

On-chain sentiment also reflects cautious positioning. Max Crypto reported that a whale has opened a $39 million ETH short position using 20x leverage, with a liquidation price near $2,187.

Large leveraged short positions do not guarantee downside, but they often signal conviction from high-capital participants. If price remains suppressed below $2,000, this positioning could reinforce bearish momentum.

A $39 million leveraged ETH short highlights growing downside pressure. Source: Max Crypto via X

However, if ETH unexpectedly squeezes above $2,100–$2,180, it could trigger short liquidations and a sharp spike in volatility. For now, positioning appears aligned with downside expectations.

Ethereum is attempting to hold near $1,930, but the technical structure remains fragile while price trades below $1,940 and well under the $2,100 resistance ceiling. Six consecutive red monthly closes reflect sustained weakness rather than short-term v

Final Thoughts: Can Ethereum Avoid a Deeper Correction?

olatility. While oversold conditions may eventually trigger relief rallies, sellers still control momentum on higher timeframes.

Ethereum was trading at around $1,940.59, down 3.20% in the last 24 hours at press time. Source: Brave New Coin

Unless bulls decisively reclaim key resistance levels, the risk of a move towards $1,700 remains elevated, making the coming sessions critical for Ethereum’s near-term trajectory.

Sorumluluk Reddi: Bu sitede yeniden yayınlanan makaleler, halka açık platformlardan alınmıştır ve yalnızca bilgilendirme amaçlıdır. MEXC'nin görüşlerini yansıtmayabilir. Tüm hakları telif sahiplerine aittir. Herhangi bir içeriğin üçüncü taraf haklarını ihlal ettiğini düşünüyorsanız, kaldırılması için lütfen [email protected] ile iletişime geçin. MEXC, içeriğin doğruluğu, eksiksizliği veya güncelliği konusunda hiçbir garanti vermez ve sağlanan bilgilere dayalı olarak alınan herhangi bir eylemden sorumlu değildir. İçerik, finansal, yasal veya diğer profesyonel tavsiye niteliğinde değildir ve MEXC tarafından bir tavsiye veya onay olarak değerlendirilmemelidir.

Ayrıca Şunları da Beğenebilirsiniz

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Paylaş
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Paylaş
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Paylaş
BitcoinEthereumNews2025/09/18 05:26